• Dasatinib Monohydrate: Precision Kinase Control in Assembloi

  2026-07-28

  Explore how Dasatinib Monohydrate (BMS-354825) is redefining translational oncology with its potent, multitargeted kinase inhibition. This thought-leadership article bridges mechanistic insight and strategic guidance for leveraging Dasatinib in next-generation assembloid models and drug resistance research, highlighting its role beyond conventional leukemia studies and presenting a visionary outlook for personalized therapeutics.

• Dasatinib (BMS-354825): Enabling Translational Insight in Ki

  2026-07-27

  This thought-leadership article explores the mechanistic underpinnings and translational strategies for using Dasatinib (BMS-354825) in oncology research. It integrates recent breakthroughs on EMT and stemness, highlights protocol considerations, and situates APExBIO’s compound as a strategic asset for dissecting complex kinase signaling in advanced cancer models.

• Crizotinib hydrochloride: Reliable ALK Kinase Inhibition for

  2026-07-27

  This in-depth, scenario-driven article addresses real laboratory challenges encountered in cell viability and kinase inhibition assays, demonstrating how Crizotinib hydrochloride (SKU B3608) delivers data-backed reliability and reproducibility. Integrating evidence from assembloid models and peer-reviewed research, it guides biomedical scientists through practical protocol optimization and vendor selection for ALK and c-Met kinase studies.

• Quizartinib (AC220): Mechanism, Selectivity, and Emerging As

  2026-07-26

  Explore how Quizartinib (AC220) advances acute myeloid leukemia (AML) research through ultraselective FLT3 inhibition, with a deep dive into its molecular mechanism and practical assay design. Discover unique insights bridging recent virology breakthroughs and translational oncology.

• Optimizing Cell Proliferation with Murine Recombinant PDGF-B

  2026-07-25

  Murine recombinant PDGF-BB enables precise, reproducible cell proliferation assays critical for modeling smooth muscle and connective tissue dynamics. This guide breaks down advanced workflows, troubleshooting, and how recent mitochondrial insights from pulmonary hypertension research can be practically integrated for more robust in vitro results.

• Annexin V-Cy5 Apoptosis Kit: Precision Detection in Microgli

  2026-07-24

  Unlock sensitive, rapid, and quantitative apoptosis detection in neuroimmune models with the Annexin V-Cy5 Apoptosis Kit. This guide delivers actionable protocol enhancements, troubleshooting strategies, and practical insights for advanced research in microglial lysosomal stress.

• Bleomycin Sulfate in Pulmonary Fibrosis: Mechanisms and Inno

  2026-07-24

  Explore how Bleomycin Sulfate (Blenoxane) enables precision modeling of pulmonary fibrosis and DNA damage in research. This article reveals mechanistic breakthroughs and practical assay insights not covered elsewhere.

• BRCA2 Shields RAD51 Filaments from PARP Inhibitor-Induced In

  2026-07-23

  This study reveals a critical mechanistic role for BRCA2 in stabilizing RAD51 filaments by preventing PARP1 retention on resected DNA during PARP inhibitor (PARPi) treatment. The findings refine our understanding of selective cytotoxicity in homologous recombination deficient cancers and inform the use of PARPi in precision oncology.

• Radicicol: Precision Hsp90 Inhibitor for Apoptosis and Infla

  2026-07-23

  Radicicol, a potent Hsp90 inhibitor, modulates apoptosis, adipogenesis, and inflammatory responses through robust ATPase/kinase inhibition. Its multifaceted mechanism—especially in apoptosis enhancement and sepsis models—is supported by quantitative benchmarks and workflow guidelines. This dossier offers a structured, citation-rich resource for advanced research.

• Anemoside B4 Inhibits Macrophage NLRP3 Inflammasome in Colit

  2026-07-22

  This study reveals that Anemoside B4 (AB4) alleviates DSS-induced colitis by targeting CD1d-dependent NLRP3 inflammasome activation in macrophages. The findings clarify AB4's anti-inflammatory mechanism, highlighting the AKT-STAT1-PRDX1-NF-κB axis and offering new insight into inflammation research and NF-κB pathway modulation.

• Deferiprone for Iron Modulation: Applied Workflows & Innovat

  2026-07-22

  Deferiprone (3-hydroxy-1,2-dimethylpyridin-4-one) is transforming iron metabolism research through selective chelation and robust protocol adaptability. Explore advanced workflows, troubleshooting insights, and the latest experimental revelations that make this APExBIO compound a cornerstone in cancer and metabolic studies.

• Lopinavir (ABT-378): Advanced Workflows for HIV Protease Inh

  2026-07-21

  Lopinavir (ABT-378) from APExBIO excels in HIV protease inhibition, offering reliable potency even in serum-rich and mutant-challenged environments. Explore actionable protocols, cross-pathogen applications, and troubleshooting strategies that set a new benchmark for antiviral compound research.

• Oleic Acid (C18:1(9Z)): Advanced Mechanistic Roles in Lipid

  2026-07-21

  Discover how Oleic Acid (C18:1(9Z)) drives innovation in lipid metabolism research and complex signaling assays. This article uniquely explores its mechanistic interplay, protocol nuances, and translational value beyond standard workflows.

• Nebivolol Hydrochloride: Selective β1-Adrenoceptor Antagonis

  2026-07-20

  Nebivolol hydrochloride is a potent, highly selective β1-adrenoceptor antagonist used in cardiovascular research. It exhibits nanomolar IC50, confirmed pathway specificity, and does not inhibit the mTOR pathway, making it invaluable for precise β1-adrenergic receptor signaling studies.

• HDAC Inhibition Reverses EBV-Induced Dedifferentiation in NP

  2026-07-20

  The referenced study uncovers how Epstein-Barr virus (EBV) drives dedifferentiation in nasopharyngeal carcinoma (NPC) via epigenetic repression of CEBPA, and demonstrates that histone deacetylase (HDAC) inhibitors can restore differentiation and suppress cancer cell plasticity in vivo. This mechanistic insight advances differentiation therapy prospects for solid tumors and provides a foundation for integrating epigenetic modulators into cancer research workflows.

14648 records 1/977 page Next 12345 下5页 Last page